Dermatology Treatment Articles & Analysis
10 news found
(ALM), a global pharmaceutical company focused on medical dermatology, and etherna, an mRNA/LNP technology platform company, announced today a multi-target alliance to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The alliance combines and leverages etherna’s innovative proprietary mRNA capabilities and LNP ...
ByeTheRNA
The Q-switched Nd YAG laser dermatology is used for the treatment of various pigmented skin diseases. ...
The main adverse reactions are pain and blood leakage during treatment and oedema after treatment, but these are normal reactions during treatment and generally do not require special treatment. ...
Picosecond laser tattoo removal machine has a wide range of applications in dermatological treatments and are used in cosmetic equipment. Picosecond laser device can remove spots, acne marks, melanin, remove tattoos, rejuvenate skin and shrink pores, among other effects. ...
An estimated 1.7 million people in Germany are currently undergoing dermatological treatment for AK. Actually, the number of patients suffering from AK is much higher and is expected to increase in the next years in line with the population structure. ...
A major study published in leading cancer journal, The Lancet Oncology1 have ground-breaking findings on Michelson Diagnostics, the UK based medical device company that use multi-beam Optical Coherence Tomography (‘OCT’) technology, which can transform patient’s treatment and care of basal cell carcinomas (BCC). It was concluded that OCT-guided diagnosis, when compared to a ...
Ng Cashin has extensive background in both infectious disease and dermatology and will be invaluable as we advance microbial-based drugs through clinical development," said AOBiome's President and CEO Todd Krueger. ...
BOSTON--(BUSINESS WIRE)-- DermBiont, Inc., a clinical-stage biotechnology company developing targeted topical therapeutics that address the root causes of skin diseases, announced today that it has raised a $28 million Series A2 financing in parallel with the acquisition of clinical-stage biotechnology company Chromaderm, which is developing a topical inhibitor of melanin production as a ...
Veregen (Polyphenon E) is currently approved for the topical treatment of external genital and perianal warts (condylomata acuminata) in immunocompetent patients older than 18 years of age. ...
Collaboration on Artificial Intelligence (AI) The collaboration between Michelson Diagnostics and Manchester Imaging will focus on creating powerful new algorithms based on machine learning and computer vision (also known as ‘Artificial Intelligence’ or AI) that will automate the analysis of images captured by the VivoSight OCT scanner, to enable dermatologists to make the right ...